NCT04557189 - A Study of TAK-951 to Stop Adults Getting Nausea and Vomiting After Planned Surgery | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 20, 2020

Primary Completion Date

March 7, 2022

Study Completion Date

March 21, 2022

Conditions

Postoperative Nausea and Vomiting (PONV)

Interventions

DRUG

TAK-951

TAK-951 SC injection

DRUG

Ondansetron

Ondansetron IV injection

DRUG

Ondansetron Placebo

Ondansetron placebo-matching IV injection

DRUG

TAK-951 Placebo

TAK-951 placebo-matching SC injection

Trial Locations (7)

Stony Brook Medicine - Hospital, Stony Brook

Phoenix Clinical Research, Tamarac

Helen Keller Hospital, Sheffield

Legent Orthopedic Hospital, Carrollton

Altus Houston Hospital - Hospital, Houston

First Street Hospital - Research, Bellaire

Lotus Clinical Research Inc, Pasadena